Adagene Inc (ADAG)

2.410 +0.08 (+3.43%) USD  |  NASDAQ  |  May 02, 16:00
More

Adagene Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ADAG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Change in Payables and Accrued Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2020 --
Date Value
September 30, 2019 --

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Sep 2019
Upgrade
Maximum
Sep 2020
Upgrade
Average
Upgrade
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

Sinovac Biotech Ltd --
CASI Pharmaceuticals Inc --
Zai Lab Ltd Upgrade
I-MAB --
Gracell Biotechnologies Inc (DELISTED) --